ロード中...
Phase I/II study of weekly irinotecan and concurrent radiation therapy for locally advanced non-small cell lung cancer
A study was undertaken to determine the maximum tolerated dose, the dose-limiting toxicities, and the response rate of irinotecan administered weekly with concurrent thoracic radiation therapy in patients with locally advanced non-small-cell lung cancer. In a phase I/II clinical trial, patients with...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1999
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362741/ https://ncbi.nlm.nih.gov/pubmed/10188891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690233 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|